Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27674 | 0.97 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1LMNA | |
| Bromide SCHEMBL7778868 | 0.95 | ALDH1A1 (0.41) | ALDH1A1TSHRDNM1LMNA | |
| Iodide SCHEMBL26983162 | 0.95 | ALDH1A1 (0.41) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL8090320 | 0.93 | ALDH1A1 (0.46) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL379316 | 0.90 | ALDH1A1 (0.48) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL22472282 | 0.89 | ALDH1A1 (0.36) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL16813858 | 0.89 | ALDH1A1 (0.36) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL329938 | 0.89 | ALDH1A1 (0.36) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL23348665 | 0.88 | ALDH1A1 (0.52) | ALDH1A1TSHRDNM1LMNA | |
| SCHEMBL21111268 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TSHRDNM1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117397697-A | Disinfectant and article coated with same | 株式会社创造产品田代 | 2024-01-16 | — | — | CN | claimed |
| CN-117138836-A | Oxide/iodine composite particles and dispersion of oxide/iodine composite particles | 中国石油化工股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| US-9403128-B2 | Nanoengineered field induced charge separation membranes manufacture thereof | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2016-08-02 | — | — | US | claimed |
| US-5225190-A | Organosilicon hair care products | DOW CORNING CORPORATION (US) | 1993-07-06 | — | — | US | claimed |
| CN-115233188-B | Sheet grade Ni-Al2O3Preparation method of porous energy material | 南京理工大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-117397697-A | Disinfectant and article coated with same | 株式会社创造产品田代 | 2024-01-16 | — | — | CN | disclosed |
| CN-117138836-A | Oxide/iodine composite particles and dispersion of oxide/iodine composite particles | 中国石油化工股份有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-11744248-B2 | Disinfectant composition for control of clostridium difficile spore | ENVIRO SPECIALTY CHEMICALS INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-20230131818-A1 | CEMENT COMPOSITION AND CURED PRODUCT THEREOF | DOW TORAY CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| EP-4103635-A1 | POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES | Sanitized AG (CH) | 2022-12-21 | — | — | EP | disclosed |
| CN-115335346-A | Precast concrete molding | 陶氏东丽株式会社 | 2022-11-11 | — | — | CN | disclosed |
| CN-115298148-A | Cement composition and cured product thereof | 陶氏东丽株式会社 | 2022-11-04 | — | — | CN | disclosed |
| CN-110804868-A | Mesoporous silicon composition for endowing fabric with antifouling and antibacterial properties and application thereof | 天津大学 | 2020-02-18 | — | — | CN | disclosed |
| WO-2019040374-A1 | DISINFECTANT COMPOSITION FOR CONTROL OF CLOSTRIDIUM DIFFICILE SPORES | ENVIRO SPECIALTY CHEMICALS INC. (US) | 2019-02-28 | — | — | WO | disclosed |
| WO-2019040376-A1 | POLYMERIC TOPICAL ANTISEPTIC COMPOUND AND METHOD OF USE | ENVIRO SPECIALTY CHEMICALS INC. (US) | 2019-02-28 | — | — | WO | disclosed |
| US-20190053495-A1 | POLYMERIC TOPICAL ANTISEPTIC COMPOUND AND METHOD OF USE | ANGRES, ISAAC A, PHD | 2019-02-21 | — | — | US | disclosed |
| US-20190053494-A1 | DISINFECTANT COMPOSITION FOR CONTROL OF CLOSTRIDIUM DIFFICILE SPORE | ENVIRO SPECIALTY CHEMICALS, INC. | 2019-02-21 | — | — | US | disclosed |
| US-8864894-B2 | Resist underlayer film forming composition containing silicone having onium group | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-10-21 | — | — | US | disclosed |
| EP-2336256-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM WITH ONIUM GROUP | Nissan Chemical Industries, Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-20110143149-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICONE HAVING ONIUM GROUP | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110143149-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICONE HAVING ONIUM GROUP | SRR, KDM2B, MSR1 | ALDH1A1 3585/4885TSHR 1944/4885DNM1 4038/4885 |
| US-11744248-B2 | Disinfectant composition for control of clostridium difficile spore | EPCAM, DSTN, DSG1 | ALDH1A1 2908/4885TSHR 3668/4885DNM1 346/4885 |
| US-20190053494-A1 | DISINFECTANT COMPOSITION FOR CONTROL OF CLOSTRIDIUM DIFFICILE SPORE | EPCAM, DSTN, DSG1 | ALDH1A1 2908/4885TSHR 3668/4885DNM1 346/4885 |
| US-20190053495-A1 | POLYMERIC TOPICAL ANTISEPTIC COMPOUND AND METHOD OF USE | CUTA, TRPV1, TRPV2 | ALDH1A1 2097/4885TSHR 2981/4885DNM1 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.